Lantern Pharma Inc. Common Stock (LTRN) is a publicly traded Healthcare sector company. As of October 8, 2026, LTRN trades at $0.91 with a market cap of $14.24M and a P/E ratio of -0.54. LTRN moved +0.00% today. Year to date, LTRN is -70.74%; over the trailing twelve months it is -80.00%. Its 52-week range spans $0.84 to $5.74. Rallies surfaces LTRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LTRN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.91 |
| Market Cap | $14.24M |
| P/E Ratio | -0.54 |
| EPS | $-1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.74 |
| 52-Week Low | $0.84 |
| Volume | 20.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-17.12M |
| Gross Margin | 0.00% |
LTRN analyst coverage data. Average price target: $0.00.